AusBiotech is proud to announce the establishment of its new Investor Readiness Panel (IRP).
The IRP will provide stage-appropriate, non-binding guidance on a company’s readiness to engage with investors. It is designed to improve the quality and effectiveness of investor conversations across the sector (for founders and investors alike) and to help avoid the frustration that often arises from stage or timing mismatches.
Panel members are appointed in their individual capacity and do not represent their organisations.
/Public Release. View in full here.
